Literature Cited

  • 1
    Andrews RG, Singer JW, Bernstein ID: Precursors of colony-forming cells in humans can be distinguished from colony forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 169: 17211731, 1989.
  • 2
    Ashman LK, Camareri AC, To LB, Levinsky RJ, Juttner CA: Expression of the YB5. B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 78: 3037, 1991.
  • 3
    Ashman LK, Roberts MM, Gadd SJ, Cooper SJ, Juttner CA: Expression of a 150 kDa cell surface antigen identified with monoclonal antibody YB5. B8 is associated with poor prognosis in acute nonlymphoblastic leukemia. Leukemia Res 12: 923929, 1988.
  • 4
    Ashman LK, Roberts MM, Gadd SJ, Cooper SJ, Juttner CA: Expression of a 150 kDa cell surface antigen identified with monoclonal antibody YB5. B8 is associated with poor prognosis in acute nonlymphoblastic leukemia. Leukemia Res 12: 923929, 1988.
  • 5
    Babior B: Oxygen-dependent microbial killing by phagocytes. N Engl J Med 298: 659664, 1978.
  • 6
    Bainton D, Ullyot J, Farquhar M: The development of neutrophilic polymorphonuclear leukocytes in human bone marrow: Origin and content of azurophilic and specific granules. J Exp Med 134: 907934, 1971.
  • 7
    Bender J, Unverzagt K, Walker D, Lee W, Van Epps D, Smith D, Steward C, To B: Identification of CD34 positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 77: 25912596, 1991.
  • 8
    Benett J, Catovsky D, Daniel M, Flandrin G, Galton D, Gralnick H, Sultan C: Proposal for the recognition of minimally differentiated acute myeloid leukemia. Br J Haematol 78: 325329, 1991.
  • 9
    Bennett J, Catovsky D, Daniel M, Flandrin G, Galton D, Gralnick H, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 103: 620625, 1985.
  • 10
    Bernstein ID, Leary AG, Andrews RG, Ogawa M: Blast colony forming cells and precursors of colony-forming cells detectable in longterm marrow culture express the same phenotype (CD33-CD34 + ). Exp Hematol 19: 680682, 1991.
  • 11
    Bettelheim P, Lutz D, Majdic O, Paietta E, Haas O, Linkesch W, Neumann E, Lechner K, Knapp W: Unexpected absence of a myeloid surface antigen (3-fucosyl-N-acetyllactosamine) in promyelocytic leukemia. Leuk Res 9: 13231327, 1985.
  • 12
    Brandt J, Srour E, van Besien K, Briddell R, Hoffmann R: Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow. J Clin Invest 86: 932941, 1990.
  • 13
    Buccheri V, Shetty V, Yoshida N, Morilla R, Matutes E, Catovsky D: The role of anti-myeloperoxidase antibody in the diagnosis and classification of acute leukemia: A comparison with light and electron microscopy cytochemistry. Br J Haematol 80: 6268, 1992.
  • 14
    Bühring HJ, Ullrich A, Schaudt K, Müller CA, Busch FW: The product of the proto-oncogene c-kit (P145 c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is overexpressed on a subset of acute non-lymphoblastic leukemic cells. Leukemia 5: 854860, 1991.
  • 15
    Campana D, Thompson J, Amlot P, Brown S, Janossy G: The cytoplasmic expression of CD3 antigens in normal and malignant cells of the T lymphoid lineage. J Immunol 138: 648653, 1987.
  • 16
    Catovsky D, Matutes E, Buccheri V, Shetty V, Hanslip J, Yoshida N, Morilla R: A classification of acute leukaemia for the 1990s. Ann Hematol. 62: 1621, 1991.
  • 17
    Civin Cl, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH: Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133: 157165, 1984.
  • 18
    Coustan-Smith E, Behm F, Hurwitz C, Rivera G, Campana D: N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acutr myeloid leukemia. Leukemia 7: 853858, 1993.
  • 19
    Cramer E, Ptryzwanzki K, Villeval J, Testa U, Breton-Gorius J: Ultrastructural localization of lactoferrin and myeloperoxidase in human neutrophils by immunogold. Blood 65: 423429, 1985.
  • 20
    Crosier P, Ricciardi S, Hall L, Vitas M, Clark S, Crosier K: Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute leukemia. Blood 82: 11511158, 1993.
  • 21
    de Vries P, Brasel KA, McKenna HJ, Williams DE, Watson JD: Thymus reconstitution by c-kit-expressing hematopoietic stem cells purified from adult mouse bone marrow. J Exp Med 176: 15031509, 1992.
  • 22
    Degos L: Annual guest lecture, Leukemia Research Fund (UK): Diofferentiation therapy and leukemia. Leukemia 7: 766772, 1993.
  • 23
    Delwel R, Bot F, Knapp W, Löwenberg B: VLM-2, a candidate monoclonal antibody for purging autologous marrow grafts in acute myeloblastic leukemia. Bone Marrow Transplantation 2: 149156, 1987.
  • 24
    Dörken B, Moldenhauer G, Pezzutto A, Schwartz R, Feller A, Kiesel S, Nadler L: HD39 (B3), a B lineage restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes. J Immunol 136: 44704476, 1986.
  • 25
    Drexler H, Ludwig W-D: Incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. In: Recent Results in Cancer Research, Vol. 131, LudwigW-D, ThielE (eds). Springer-Verlag, Berlin, 1993, pp 5366.
  • 26
    Ema H, Suda T, Miura Y, Nakauchi H: Colony formation of clonesorted human hematopoietic progenitors. Blood 75: 19411946, 1990.
  • 27
    Gadd S, Majdie O, Kasinrerk W, Stockinger H, Maurer D, Eher R, Knapp W: M5, a phosphoinositol linked human myelomonocytic activation associated antigen. Clin Exp Immunol 80: 252256, 1990.
  • 28
    Gadd SJ, Ashman LK: A murine monoclonal antibody specific for a cell-surface antigen expressed by a subgroup of human myeloid leukaemias. Leukemia Res 9: 13291336, 1985.
  • 29
    Geller R, Zahurak M, Hurwitz C, Burke P, Karp J, Piantadosi S, Civin C: Prognostic importance of immunophenotyping in adults with acute myelocytic leukemia: The significance of the stem-cell glykorotein CD34 (My10),. Br J Haematol 76: 340347, 1990.
  • 30
    Hollas W, Blasi F, Boyd D: Role of urikinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. Cancer Res 51: 36903695, 1991.
  • 31
    Holnes CL, Simmons DL: Molecular cloning of CD68, a human macrophage marker related to lysosomal glykoproteins. Blood 81: 16071613, 1993.
  • 32
    Holowiecki J, Lutz D, Krzemien S, Graf F, Keleney G, Brugiatelly M, Callea V, Holowiecka B, Jagoda K, Ihle K, Krc I: Expression of CD15 antigen on leukemic cells—a new prognostic factor for ability to achieve complete remission and for survival in ANLL. In: Acute Leukemias, vol. 30, BüchnerT, SchellongG, HiddemannW, UrbanitzD, RitterJ (eds). Springer-Verlag, Berlin, 1987, pp 361364.
  • 33
    Hurwitz CA, Raimondi SC, Head D, Krance R, Mirro J, Kalwinsky DK, Ayers GD, Behm FG: Distinctive immunophenotypic features of t(8;21) (q22;q22) acute myeloblastic leukemia in children. Blood 80: 31823188, 1992.
  • 34
    Ikeda H, Kanakura Y, Tamaki T, Kuriu A, Kitayama H, Ishikawa J, Kanayama Y, Yonezawa T, Tarui S, Griffin J: Expression and functional role of c-kit in acute myeloblastic leukemia. Blood 11: 29622968, 1991.
  • 35
    Janossy G, Coustan-Smith E, Campana D: The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: A study of 500 cases. Leukemia 3: 170178, 1989.
  • 36
    Kirchheimer JC, Remold HG: Endogeneous receptor-bound urokinase mediates tissue invasion of human monocytes. J Immunol 143: 26342641, 1989.
  • 37
    Kita K, Nakase K, Miwa H, Masuya M, Nishii K, Morita N, Takakur N, Otsuji A, Shirakawa S, Ueda T, Nasu K, Kyo T, Dohy H, Kamada N: Phenotypic characteristics of acute myclocytic leukemia associated with the t(8;21) (q22;q22) chromosomal abnormality: Frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 80: 470477, 1992.
  • 38
    Knapp W: Antibody defined surface molecules of normal and malignant hemopoietic cells. In: Flow Cytometry in Hematology, LacrumOD, BjerknesR (eds). Academic Press, London, 1992. pp 213230.
  • 39
    Knapp W, Majdic O, Naurer D, Gschwantler E, Strobl H: Antigenic analysis of CD34+ human hemopoietic progenitor cells. In: Molecular Biology of Haematopoiesis, Vol. 3, AbrahamsNG, MarksP, KonwalinkaG, SachsL, TavassoliM (eds). Intercept, Andover, 1992, pp 277290.
  • 40
    Knapp W, Majdic O, Strobl H: Flow cytometric analysis of intracellular myeloperoxidase and lactoferrin in leukemia diagnosis. In: Recent Results in Cancer Research, Vol. 131, LudwigW-D, ThielE (eds). Springer-Verlag, Berlin, 1993, pp 3240.
  • 41
    Koeffler HP, Ranyard J, Pertcheck M: Myeloperoxidase: Its structure and expression during maeloid differentiation. Blood 65: 484491, 1985.
  • 42
    Kwong YL, Ching LM, Liu HW, Lee CP, Pollock A, Chan LC: 8;21 translocation and multilineage involvement. Am J Hematol 43: 212216, 1993.
  • 43
    Leary A, Ogawa M: Blast cell colony assay for umbilical cord blood and adult bone marrow progenitors. Blood 69: 953956, 1987.
  • 44
    Lerner NB, Nocka KH, Cole SR, Qiu F, Strife A, Ashman LK, Besmer P: Monoclonal antibody YB5. B8 identifies the human c-kit protein product. Blood 77: 18761883, 1991.
  • 45
    Lis H, Sharon N: Lectin-carbohydrate interactions. Current Opinion in Structural Biology 1: 741749, 1991.
  • 46
    Macher B, Buehler J, Scudder P, Knapp W, Feizi T: A novel carbohydrate differentiation antigen on fucogangliosides of human myeloid cells recognized by monoclonal antibody VIM-2. J Biol Chem 263: 1018610191, 1988.
  • 47
    Majdic O, Liszka K, Lutz D, Knapp W: Myeloid differentiation antigen defined by monoclonal antibody. Blood 58: 11271133, 1981.
  • 48
    Mason D, Cordell J, Tse A, van Dongen J, Van Noesel C, Micklem K, Pulford K, Valensi F, Comans-Bitter W, Borst J, Gatter K: The IgM-associated protein mb-1 as a marker of normal and neoplastic B-cells. J Immunol 147: 24742482, 1991.
  • 49
    Mason D, Stein H, Gerdes J, Pulford K, Ralfkiaer E, Falini B, Erber W, Michaelm K, Gatter K: Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells. Blood 69: 836842, 1987.
  • 50
    Matos ME, Schnier GS, Beecher MS, Ashman LK, Williams DE, Caligiuri MA: Expression of a functional c-kit receptor on a subset of natural killer cells. J Exp Med 178: 10791084, 1993.
  • 51
    Min HY, Semnani R, Mizukami IF, Watt K, Todd RFI, Liu DY: cDNA for Mo3, a monocyte activation antigen, encodes the human receptore for urokinase plasinogen activator. J Immunol 148: 36363642, 1992.
  • 52
    Mirro J, Zipfer T, Pui C, Kitchingman G, Williams D, Melvin S, Murphy S, Stass S: Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance. Blood 66: 11151123, 1985.
  • 53
    Moore M: Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 78: 119, 1991.
  • 54
    Murao S, Stevens F, Ito A, Hubermann E: Myeloperoxidase: A myeloid cell nuclear antigen with DNA-binding properties. Proc Natl Acad Sci USA 12321236, 1988.
  • 55
    Nadler LM, Anderson KC, Marti G, Bates M, Park E, Daley JF, Schlossman SF: B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol 131: 244250, 1983.
  • 56
    Nishii K, Kita K, Miwa H, Kawakami K, Nakase K, Masuya M, Morita N, Omay SB, Otsuji N, Fukumoto M: c-kit gene expression in CD7-positive acute lymphoblastic leukemia: Close correlation with expression of myeloid-associated antigen CD13. Leukemia 6: 662668, 1992.
  • 57
    Ossowski L: In vivo invasion of modified chorioallantoic membrane by tumor cells: The role of cell surface-bound urokinase. J Cell Biol 107: 24372445, 1988.
  • 58
    Papayannopoulou T, Brice M, Broudy VC, Zsebo KM: Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: Functional properties and composite antigenic profile. Blood 78: 14031412, 1991.
  • 59
    Radzun HJ, Kreipe H, Zavaza N, Hansmann ML, Parwaresch MR: Diversity of the human monocyte/macrophage system as detected by monoclonal antibodies. J Leuk Biol 43: 4150, 1988.
  • 60
    Peschel C, Konwalinka G, Geissler D, Majdic O, Stockinger H, Braunsteiner H, Knapp W: Studies on differentiation of committed hemopoietic progenitor cells with monoclonal antibodies directed against myeloid differentiation antigens. Exp Hematol 13: 12111216, 1985.
  • 61
    Pui C, Hancock M, Head D, Rivera G, Look A, Sandlund J, Behm F: Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia. Blood 82: 889894, 1993.
  • 62
    Rado T, Bollekens J, Laurent G, Parker L, Benz J: Lactoferrin biosynthesis during granulocytopoiesis. Blood 64: 11031119, 1984.
  • 63
    Rani S, de Oliveiry M, Catovsky D: Differential expression of CD3 and CD22 in leukemic cells according to whether tested in suspension or fixed on slides. Hematol Pathol 2: 7380, 1988.
  • 64
    Rolink A, Melchers F: Generation and regeneration of cells of the B-lymphocyte lineage. Curr Opin Immunol 5: 207217, 1993.
  • 65
    Rolink A, Streb M, Nishikawa SI, Melchers F: The c-kit-encoded tyrosine kinase regulates the proliferation of early pre-B cells. Eur J Immunol 21: 26092612, 1991.
  • 66
    Ronne E, Behrendt N, Ellis V, Ploug M, Dano K, Hoyer Hansen G: Cell-induced potentiation of the plasinogen activation system is abolished by a monoclonal antibody that recognizes the NH2 terinal domain of the urokinase receptor. FEBS Lett 288: 233236, 1991.
  • 67
    Schwarzinger I, Valent P, Köller U, Marosi C, Schneider B, Haas O, Knapp W, Lechner K, Bettelheim P: Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia. J Clin Oncol 8: 423430, 1990.
  • 68
    Sealand S, Duvert V, Caux CPD, Favre C, Valle A, Durand I, Charbord P, de Vries J, Bancherau J: Distribution of surface-membrane molecules on bone marrow and cord blood CD34+ hematopoietic cells. Exp Hematol 20: 2433, 1992.
  • 69
    Serke S, Säuberlich S, Huhn D: Multiparameter flow-cytometrical quantitation of circulating CD34+ - cells: Correlation to the quantitation of circulating haemopoietic progenitor cells by in vitro colony-assay. Brit J Haematol 77: 453459, 1991.
  • 70
    Solary E, Casasnovas R, Campos L, Bene M, Faure G, Maingon P, Falkenrodt A, Lenormand B, Genetet N: Surface markers in adult acute myeloblastic leukemia: Correlation of CD19+, CD34+ and CD14+/DR-phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucemies (GEIL). Leukemia 6: 393399, 1992.
  • 71
    Srivastavar C, Rado T, Bauerle D, Broxmeyer H: Regulation of human bone marrow lactoferrin and myeloperoxidase gene expression by tumor necrosis factor-a. J Immunol 146: 10141021, 1991.
  • 72
    Stockinger H: Cluster report: CD68. In: Leukocyte Typing IV White Cell Differentiation Antigens, KnappW, DörkenB, GilksWR, RieberEP, SchmidtRE, SteinH, von dem BorneAEGK (eds). Oxford University Press, Oxford, 1989, pp 841843.
  • 73
    Strobl H, Takimoto M, Majdic O, Fritsch G, Scheinecker C, Höcker P, Knapp W: Myeloperoxidase expression in CD34+ normal human hemopoietic cells. Blood 82: 20692078, 1993.
  • 74
    Strobl H, Takimoto M, Majdic O, Höcker P, Knapp W: Antigenic analysis of human haemopoietic progenitor cells expressing the growth factor receptor c-kit. Brit J Haematol 82: 287294, 1992.
  • 75
    Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM: Characterization and partial purification of human marrow cells capable of initiation of long-term hematopoiesis in vitro. Blood 74: 15631570, 1989.
  • 76
    Terstappen LWMM, Huang S, Safford M, Lansdorp PM, Loken MR: Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34 + CD38— progenitor cells. Blood 77: 110, 1991.
  • 77
    Tiemeyer M, Swiedler S, Ishihara M, Moreland M, Schweingruber H, Hirtzer P, Brandley B: Carbohydrate ligands for endothelial-leukocyte adhesion molecule-1. Proc Natl Acad Sci USA 88: 11381142, 1990.
  • 78
    Tjonnfjord G, Veiby O, Steen R, Egeland T: T lymphocyte differentiation in vitro from adult human prethymic CD34 + bone marrow cells. J Exp Med 177: 15311539, 1993.
  • 79
    Vainchenker W, Villeval J, Tabilio E, Matamis H, Karanakis G, Guichard J, Henri A, Vernant J, Rochant H, Breton-Gorius J: Immunophenotype of leukemic blasts with small peroxidas-positive grnules detected by electron microscopy. Leukemia 2: 274281, 1988.
  • 80
    Van der Schoot C, Daams G, Pinkster J, Vet R, Von em Borne A: Monoclonal antibodies against myeloperoxidase are valuable immunological reagents for the diagnosis of acute myeloid leukemia. Br J Haematol 74: 173178, 1990.
  • 81
    Van der Schoot C, Von dem Borne A, Tetteroo P: Characterization of myeloid leukemias by antibodies, with an emphasis on antibodies against myeloperoxidase. Acta Hematol 78: 3240, 1987.
  • 82
    Van Dongen J, Adriaansen H, Hooijkaas H: Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies. Blood 71: 603612, 1988.
  • 83
    Vassali JD, Baccino D, Belin D: A cellular binding site for the Mv 55.000 form of the human plasminogen urokinase. J Cell Biol 100: 8691, 1985.
  • 84
    Vassalli J-D, Sappino A-P, Belin D: The plasminogen activator/plasmin system. J Clin Invest 88: 10691072, 1991.
  • 85
    Verfaillie C, Blakolmer K, McGlave P: Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulsating capacity adhere selectively to irradiated bone marrow stroma. J Exp Med 172: 509520, 1990.
  • 86
    Walz G, Aruffo A, Kolanus W, Beliavacqua M, Seed B: Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science 250: 11321135, 1990.
  • 87
    Wang C, Curtis JE, Geissler EN, McCulloch EA, Minden MD: The expression of the proto-oncogene c-kit in the blast cells of acute myeloblastic leukemia. Leukemia 3: 699702, 1989.
  • 88
    Warnke RA, Pulford K. A. F., Pallesen G, Ralfkiaer E, Brown DC, Gatte KC, Mason DY: Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1. AJP 135: 10891095, 1989.
  • 89
    Witte O: Steel locus defines new multipotent growth factor. Cell 63: 56, 1990.